gip and glp 1 drugs Emerging Role of Dual GLP-1 Receptor Agonists | DMSO GIPR/GLP-1R dual agonist therapies for
Description
Munoz-Mantilla D

Back Toiv, B (30 July 2013) 'Dr
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
doi: 10.1038/S41598-025-99622-4 128 GuoJWeiMZhangWJiangYLiAWangCet al
doi:10.1016/j.endinu.2019.05.004 35

Observational studies indicate a potential reduced risk of developing dementia, including Alzheimers, in patients using GLP-1 agonists [16, 23]

Adverse drug reactions of GLP-1 agonists: A systematic review of case reports